F-18 FDG PET Findings for Vogt-Koyanagi-Harada Disease
10.1007/s13139-015-0384-7
- Author:
Hye Lim PARK
1
;
Ie Ryung YOO
;
Sonya Youngju PARK
Author Information
1. Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul 06591, Korea. iryoo@catholic.ac.kr
- Publication Type:Case Report
- Keywords:
Vogt-Koyanagi-Harada disease;
FDG;
Positron-emission tomography;
Magnetic resonance imaging;
Seizure
- MeSH:
Aphasia;
Choroid;
Dysarthria;
Ear, Inner;
Headache;
Hearing Loss;
Magnetic Resonance Imaging;
Meninges;
Meningism;
Muscle Weakness;
Neurologic Manifestations;
Paresis;
Positron-Emission Tomography;
Psychotic Disorders;
Seizures;
Skin;
Uveomeningoencephalitic Syndrome;
Vertigo;
Visual Acuity
- From:Nuclear Medicine and Molecular Imaging
2017;51(2):190-192
- CountryRepublic of Korea
- Language:English
-
Abstract:
Vogt-Koyanagi-Harada disease is a rare multisystemic granulomatous autoimmune disorder affecting pigmented tissues such as the choroid, meninges, inner ear, and the skin. Neurologic symptoms are usually mild. Clinical manifestations include generalized muscle weakness, headache, meningismus, vertigo, decreased visual acuity, hearing loss and mental changes ranging from mild confusion to psychosis, hemiparesis, dysarthria, and aphasia. Seizures are very rare. We describe a case of ¹⁸F-fluorodeoxyglucose (F-18 FDG) positron emission tomography (PET) and software-fused PET-magnetic resonance imaging (MRI) in Vogt-Koyanagi-Harada disease with seizure.
